A novel juxtamembrane domain in tumor necrosis factor receptor superfamily molecules activates Rac1 and controls neurite growth

Molecular Biology of the Cell

Volumn 19, Issue 8, 2008, Pages 3192-3202

  Ruan, Wenjing ^a   Lee, Christopher T ^a,b   Desbarats, Julie ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; FAS ANTIGEN; RAC1 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GENE DELETION; GROWTH REGULATION; HUMAN; HUMAN CELL; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL MEMBRANE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

ANIMALS; ANTIGENS, CD95; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; NEURITES; NEURONS; PROTEIN STRUCTURE, TERTIARY; RAC1 GTP-BINDING PROTEIN; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 50249118029     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-02-0161     Document Type: Article

References (57)

1. Aggarwal, B. B. (2003). Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745-756.
2. Ahn, J. H., Park, S. M., Cho, H. S., Lee, M. S., Yoon, J. B., Vilcek, J., and Lee, T. H. (2001). Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-kappaB-dependent gene expression. J. Biol. Chem. 276, 47100-47106.
3. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F., and Lynch, D. H. (1993). Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178, 2231-2235.
4. Alderson, M. R., Tough, T. W., Braddy, S., Davis-Smith, T., Roux, E., Schooley, K., Miller, R. E., and Lynch, D. H. (1994). Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol. 6, 1799-1806.
5. Barcena, A., Muench, M. O., Song, K. S., Ohkubo, T., and Harrison, M. R. (1999). Role of CD95/Fas and its ligand in the regulation of the growth of human CD34(++)CD38(-) fetal liver cells. Exp. Hematol. 27, 1428-1439.
6. Barnhart, B. C., Legembre, P., Pietras, E., Bubici, C., Franzoso, G., and Peter, M. E. (2004). CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J. 23, 3175-3185.
7. Becher, B., Barker, P. A., Owens, T., and Antel, J. P. (1998). CD95-CD95L: can the brain learn from the immune system? Trends Neurosci. 21, 114-117.
8. Bechmann, I., Mor, G., Nilsen, J., Eliza, M., Nitsch, R., and Naftolin, F. (1999). FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Glia 27, 62-74.
9. Biancone, L., Martino, A. D., Orlandi, V., Conaldi, P. G., Toniolo, A., and Camussi, G. (1997). Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J. Exp. Med. 186, 147-152.
10. Bretscher, A. (1999). Regulation of cortical structure by the ezrin-radixin-moesin protein family. Curr. Opin. Cell Biol. 11, 109-116.
11. Brunner, T. et al. (1995). Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444.
12. Charrin, S., and Alcover, A. (2006). Role of ERM (ezrin-radixin-moesin) proteins in T lymphocyte polarization, immune synapse formation and in T cell receptor-mediated signaling. Front. Biosci. 11, 1987-1997.
13. Cheng, L., Itoh, K., and Lemmon, V. (2005). L1-mediated branching is regulated by two ezrin-radixin-moesin (ERM)-binding sites, the RSLE region and a novel juxtamembrane ERM-binding region. J. Neurosci. 25, 395-403.
14. Choi, C., Gillespie, G. Y., Van Wagoner, N. J., and Benveniste, E. N. (2002). Fas engagement increases expression of interleukin-6 in human glioma cells. J. Neurooncol. 56, 13-19.
15. Curto, M., and McClatchey, A. I. (2004). Ezrin. A metastatic detERMinant? Cancer Cell 5, 113-114.
16. Desbarats, J., Birge, R. B., Mimouni-Rongy, M., Weinstein, D. E., Palerme, J. S., and Newell, M. K. (2003). Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5, 118-125.
17. Desbarats, J., and Newell, M. K. (2000). Fas engagement accelerates liver regeneration after partial hepatectomy. Nat. Med. 6, 920-923.
18. + T cell responses to Fas (CD95) engagement. Proc. Natl. Acad. Sci. USA 96, 8104-8109.
19. Dhein, J., Walczak, H., Baumler, C., Debatin, K.-M., and Krammer, P. H. (1995). Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-441.
20. Fais, S. (2004). A role for ezrin in a neglected metastatic tumor function. Trends Mol. Med. 10, 249-250.
21. Fais, S., De Milito, A., and Lozupone, F. (2005). The role of FAS to ezrin association in FAS-mediated apoptosis. Apoptosis 10, 941-947.
22. French, L. E., and Tschopp, J. (1996). Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune protection and cell turnover. Behring Inst. Mitteilungen 97, 156-160.
23. Gimeno, L., Corradi, A., Cobos, I., Consalez, G. G., and Martinez, S. (2004). Ezrin gene, coding for a membrane-cytoskeleton linker protein, is regionally expressed in the developing mouse neuroepithelium. Gene Expr. Patterns 4, 749-754.
24. Haas, M. A., Vickers, J. C., and Dickson, T. C. (2004). Binding partners L1 cell adhesion molecule and the ezrin-radixin-moesin (ERM) proteins are involved in development and the regenerative response to injury of hippocampal and cortical neurons. Eur. J. Neurosci. 20, 1436-1444.
25. Haouzi, D., Baghdiguian, S., Granier, G., Travo, P., Mangeat, P., and Hibner, U. (2005). Three-dimensional polarization sensitizes hepatocytes to Fas/CD95 apoptotic signalling. J. Cell Sci. 118, 2763-2773.
26. Huang, B., Eberstadt, M., Olejniczak, E. T., Meadows, R. P., and Fesik, S. W. (1996). NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 384, 638-641.
27. Ivetic, A., and Ridley, A. J. (2004). Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes. Immunology 112, 165-176.
28. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothstein, A. (1995). Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
29. Kauppila, S. et al. (2003). Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila. Oncogene 22, 4860-4867.
30. Lambert, C., Landau, A. M., and Desbarats, J. (2003). Fas-beyond death: a regenerative role for Fas in the nervous system. Apoptosis 8, 551-562.
31. Landau, A. M., Luk, K. C., Jones, M. L., Siegrist-Johnstone, R., Young, Y. K., Kouassi, E., Rymar, V. V., Dagher, A., Sadikot, A. F., and Desbarats, J. (2005). Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease. J. Exp. Med. 202, 575-581.
32. Lozupone, F., Lugini, L., Matarrese, P., Luciani, F., Federici, C., Iessi, E., Margutti, P., Stassi, G., Malorni, W., and Fais, S. (2004). Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin. J. Biol. Chem. 279, 9199-9207.
33. Luciani, F., Matarrese, P., Giammarioli, A. M., Lugini, L., Lozupone, F., Federici, C., Iessi, E., Malorni, W., and Fais, S. (2004). CD95/phosphorylated ezrin association underlies HIV-1 GP120/IL-2-induced susceptibility to CD95(APO-1/Fas)-mediated apoptosis of human resting CD4(+)T lymphocytes. Cell Death Differ 11, 574-582.
34. Manser, E., Leung, T., Salihuddin, H., Zhao, Z. S., and Lim, L. (1994). A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 40-46.
35. Martin-Villalba, A., Hahne, M., Kleber, S., Vogel, J., Falk, W., Schenkel, J., and Krammer, P. H. (2001). Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ. 8, 679-686.
36. Meyer, G., and Feldman, E. L. (2002). Signaling mechanisms that regulate actin-based motility processes in the nervous system. J. Neurochem. 83, 490-503.
37. Nagata, S., and Golstein, P. (1995). The Fas death factor. Science 267, 1449-1456.
38. Nikolic, M. (2002). The role of Rho GTPases and associated kinases in regulating neurite outgrowth. Int. J. Biochem. Cell Biol. 34, 731-745.
39. O'Brien, D., O'Connor, T., Shanahan, F., and O'Connell, J. (2002). Activation of the p38 MAPK and ERK1/2 pathways is required for Fas-induced IL-8 production in colonic epithelial cells. Ann. N Y Acad. Sci. 973, 161-165.
40. Parlato, S., Giammarioli, A. M., Logozzi, M., Lozupone, F., Matarrese, P., Luciani, F., Falchi, M., Malorni, W., and Fais, S. (2000). CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19, 5123-5134.
41. Peter, M. E. et al. (2007). The CD95 receptor: apoptosis revisited. Cell 129, 447-450.
42. Peter, M. E., and Krammer, P. H. (2003). The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10, 26-35.
43. Peter, M. E., Legembre, P., and Barnhart, B. C. (2005). Does CD95 have tumor promoting activities? Biochim. Biophys. Acta 1755, 25-36.
44. Ramaswamy, M., Dumont, C., Cruz, A. C., Muppidi, J. R., Gomez, T. S., Billadeau, D. D., Tybulewicz, V.L.J., and Siegel, R. M. (2007). Rac GTPases sensitize activated T cells to die via Fas. J. Immunol. 179, 6384-6388.
45. Raoul, C., Estevez, A. G., Nishimune, H., Cleveland, D. W., deLapeyriere, O., Henderson, C. E., Haase, G., and Pettmann, B. (2002). Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron 35, 1067-1083.
46. Ricci-Vitiani, L., Pedini, F., Mollinari, C., Condorelli, G., Bonci, D., Bez, A., Colombo, A., Parati, E., Peschle, C., and De Maria, R. (2004). Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. J. Exp. Med. 200, 1257-1266.
47. Sakic, B., Szechtman, H., Denburg, J., Gorny, G., Kolb, B., and Whishaw, I. (1998). Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J. Neuroimmunol. 87, 162-170.
48. Shinohara, H., Yagita, H., Ikawa, Y., and Oyaizu, N. (2000). Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase. Cancer Res. 60, 1766-1772.
49. Takahashi, K., Sasaki, T., Mammoto, A., Takaishi, K., Kameyama, T., Tsukita, S., and Takai, Y. (1997). Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J. Biol. Chem. 272, 23371-23375.
50. Tamm, C., Robertson, J. D., Sleeper, E., Enoksson, M., Emgard, M., Orrenius, S., and Ceccatelli, S. (2004). Differential regulation of the mitochondrial and death receptor pathways in neural stem cells. Eur. J. Neurosci. 19, 2613-2621.
51. Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M., and Krammer, P. H. (1989). Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305.
52. Tsukita, S., and Yonemura, S. (1999). Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. J. Biol. Chem. 274, 34507-34510.
53. Tsutsui, H. et al. (1999). Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11, 359-367.
54. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. (1992). Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
55. Yang, H. S., and Hinds, P. W. (2006). Phosphorylation of ezrin by cyclin-dependent kinase 5 induces the release of Rho GDP dissociation inhibitor to inhibit Rac1 activity in senescent cells. Cancer Res. 66, 2708-2715.
56. Yonehara, S., Ishii, A., and Yonehara, M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
57. Zuliani, C. et al. (2006). Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ 13, 31-40.